Global Cord Blood (NYSE:CO) Share Price Passes Above 200 Day Moving Average – Time to Sell?

Global Cord Blood Co. (NYSE:COGet Free Report)’s stock price passed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $1.03 and traded as high as $1.26. Global Cord Blood shares last traded at $1.19, with a volume of 42,087 shares traded.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen started coverage on Global Cord Blood in a research note on Saturday, May 17th. They issued a “strong-buy” rating on the stock.

View Our Latest Report on Global Cord Blood

Global Cord Blood Stock Up 18.5%

The company has a market cap of $144.04 million, a PE ratio of 1.85 and a beta of 0.16. The stock has a 50-day simple moving average of $0.98 and a 200 day simple moving average of $1.03.

About Global Cord Blood

(Get Free Report)

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.

Read More

Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.